Atea Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $94,072,000.
Profit Margin
| 2018 | 0 | -9.06M | |
|---|---|---|---|
| 2019 | 0 | -13.46M | |
| 2020 | 48.63M | -10.86M | -22.34% |
| 2021 | 351.36M | 121.19M | 34.49% |
| 2022 | 0 | -115.90M | |
| 2023 | 0 | -135.95M |
AVIR Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 351.36M | 48.63M | 0 | 0 |
Cost of revenue | 70.09M | 260K | 29K | 19K | 17K | 0 |
Gross profit | -70.09M | -260K | 351.33M | 48.61M | -17K | 0 |
Operating exp. | ||||||
Research and development | 132.84M | 81.93M | 167.20M | 38.02M | 10.17M | 6.67M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 94.07M | 130.65M | 212.99M | 59.66M | 14.60M | 9.47M |
Operating income | -164.16M | -130.65M | 138.37M | -11.03M | -14.60M | -9.47M |
Other income (expenses), net | 29.22M | 11.15M | 213K | 83K | 574K | 413K |
Income before tax | -134.93M | -119.49M | 138.59M | -10.94M | -14.03M | -9.06M |
Income tax expense | 1.01M | -3.59M | 17.4M | -83K | -574K | 413K |
Net income | -135.95M | -115.90M | 121.19M | -10.86M | -13.46M | -9.06M |
Earnings per share | ||||||
Basic EPS | -1.63 | -1.39 | 1.46 | -0.13 | -0.16 | -0.19 |
Diluted EPS | -1.63 | -1.39 | 1.37 | -0.13 | -0.16 | -0.19 |
| Data source | Data source | Data source |